Shanghai PerHum Therapeutics Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Shanghai PerHum Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas (NCT05128786) | Shanghai PerHum Therapeutics Co., Ltd. | 2021-12-30 |
| A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors (NCT04511871) | Shanghai PerHum Therapeutics Co., Ltd. | 2020-07-09 |
| A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors (NCT03960060) | Shanghai PerHum Therapeutics Co., Ltd. | 2019-05-16 |
| Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma (NCT03393936) | Shanghai PerHum Therapeutics Co., Ltd. | 2018-03-26 |
Track Shanghai PerHum Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.